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Abstract
Background: Ischemia is the most important factor compromises wound healing in colonic
anastomosis. Mesenteric vessels are ligated at first while performing colonic resection and following
anastomosis. Therefore blood supply of the related segments of colon temporarily interrupted and
ischemia can easily occur. This study was carried out to explore whether Bosentan, an endothelin-
receptor antagonist, can eliminate vasoconstruction, increase blood flow in the splanchnic area and
anastomotic region and therefore possibly facilitate wound healing and prevent intra-abdominal
adhesion formation.
Metods: Study is conducted on 30 female Wistar-Albino rats weighing 180–240 gr. Rats were
allocated into three groups. Group 1 (n = 10) recevied full-thickness resection of the left colon and
end-to-end anastomosis. In Groups 2 (n = 10) and 3 (n = 10), vessels of 2–3 cm segment of the left
colon were ligated, indications of necrosis of that segment were expected, followed by resection
and end-to-end anastomosis. Two milliliter of saline and 5 mg/kg Bosentan was given
intraperitoneally in Group 2 and 3, respectively. On postoperativ day 6, intra-abdominal adhesions
were scored. Healing of anastomosis, anastomotic bursting pressures, tissue hydroxyproline levels
and histopatologically healing scores were assessed.
Results: Macroscopic adhesion score in Group 3 was lower than the remained groups (p < 0.05).
Tissue hydroxyproline levels were significantly higher in Group 3 compared to the Groups 1 and
2 (p < 0.001). Mean anastomotic bursting pressures were 200 mmHg, 164 mmHg and 240 mmHg
in Groups 1, 2 an 3, respectively (p < 0.05 between Groups 1 and 3; p < 0.001 between Groups 2
and 3). Histopathologically, healing scores of Group 1 were significantly higher than the other
groups (p < 0.05 group 1–3, group 2–3).
Conclusion:  Bosentan increases anastomotic healing of ischemic colonic anastomosis and
decreases intra-abdominal adhesion formation.
Background
Single-stage resection and anastomosis of lthe left colon
has important advantages in reducing the hospitalization
period, decreasing mortality and morbidity and protect-
ing the patient from stoma. Anastomotic leak (15%),
wound infection (50%) and intra-abdominal abscesses
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can be seen following colon resection (without colon
cleansing) and primary anastomosis (RPA) of the left
colon. There are numerous factors that disturb wound
healing at the site of colon anastomosis. These include
tension on the anastomosis, ischemia, distal obstruction,
infection, surgical technique, malnutrition, certain drugs
and disorders of collagen metabolism. Among these,
ischemia is the most important factor [1-3]. The first step
before the resection and anastomosis of colon is the liga-
tion of mesenteric vessels. During this procedure the
related segment of colon is exposed to ischemia for some
time. Following the anastomosis ischemia can also occur
on the suture line.
Drugs that inhibit vasoconstriction and increase blood
flow may contribute to rapid wound healing on the anas-
tomotic site. Endothelins are known the most potent
vasoconstrictors. In addition to this effect, they play roles
in water and electrolyte balance, regulation on the release
of certain hormones, cell proliferation and vascular per-
meability [4,5]. Increased local endothelin has been
shown to be the cause of increased vascular resistance in
experimental strangulated small bowel obstruction model
[6]. Three types of endothelin receptors, ETA, ETB, and ETC
have been identified. Bosentan (Ro 47-0203) is a compet-
itive antagonist of both ETA and ETB. It has been shown
that Bosentan inhibited the increase in vascular resistance
in strangulated small bowel [6]. Although the exact cause
of intra-abdominal adhesion formation is unknown,
ischemia is the most frequently implicated factor [7].
Recent English literature has not been focused on the
effects of Bosentan on colonic wound healing and intra-
abdominal adhesion formation.
The objective of this study was to determine the effect of
Bosentan on ischemic colon anastomosis and intra-
abdominal adhesion formation.
Materials and methods
Selection of rats
Upon an approval was obtained from the Ethics Board,
this study was conducted to laboratories of Firat Univer-
sity Faculty of Medicine Experimental Research Center
(FUTDAM), using 30 female Wistar-Albino rats weighing
180–240 g. Rats were fed standard pellet and tap water
and were kept in room temperature and humidity control-
led environment. Rats were randomly allocated to one of
three groups containig 10 rats each.
Group 1 (G1): normal resection + anastomosis
Group 2 (G2): ischemia + resection + anastomosis
Group 3 (G3): ischemia + resection + anastomosis +
Bosentan
Operation procedure
Intramuscular 35 mg/kg Ketamin HCl (Ketalar, 50 mg/ml,
Eczacibasi, Istanbul) and 5 mg/kg Xylazine HCl
(Rompun, 23.32 mg/ml, Bayer, Istanbul) was injected to
the right and left hind legs, respectively, to induce
anesthesia in all groups. About 5 minutes prior to the
operation the abdomen was shaved, cleaned with 10%
Povidon iodine solution and draped with sterile drapes.
Using sterile instruments, laparotomy was performed by
midline incision. Group 1 received resection of the left
colon 2.5 cm above the pelvic peritoneum and end-to-end
anastomosis. Two milliliters of saline was administered in
the peritoneal cavity. The abdomen was closed by 3/0 silk
sutures. In Groups 2 and 3, mesenteric vessels of the 2–3
cm segment of the left colon 2.5 cm above the pelvic per-
itoneum was ligated with 4/0 silk suture thread. One hour
following the procedure, at least one of the signs of pre-
necrosis were evident, segment of the colon was trans-
sected end-to-end anastomosis was carried out. In Group
2, 2 ml of saline and in Group 3, 5 mg/kg Bosentan was
administered into the peritoneal cavity following the pro-
cedure. All groups end-to-end anastomosis was per-
formed by full-thickness continuous sutures using 5/0
PDS. Rats were allowed water and standart laboratory
feeding 24 hours following the operation. Rats were sacri-
ficed on postoperative day 6.
Bosentan (Ro 470203) sodium was obtained to courtesy
of Dr. Martine Clozel (F. Hoffman-La Roche Ltd, Basel,
Switzerland). Twenty milligrams of Bosentan was dis-
solved in 20 ml distilled water and added to 20 ml saline
to a total of 40 ml and diluated to obtain 1 mg Bosentan
sodium in 2 ml. Dose selection was based on the results
of previous studies [6,8]
Assessment of adhesion formation
On postoperative day 6, all rats wer anesthesised, sutures
were removed and the abdomen was opened to evaluate
the healing of the anastomosis and adhesion formation.
Intra-abdominal adhesions were assessed and graded by
two surgeons blind to the groups of the rats using a stand-
ard scale according to the following criteria [9]. O point:
No adhesion; 1 point: Single, easily dissectible adhesion;
2 points: Multiple, easily dissectible adhesion; 3 points:
Single, dense adhesion; 4 points: Multiple, dense adhe-
sions.
Measuring the bursting pressure of the anastomosis site
Once the intra-abdominal adhesions were scored, with-
out dissecting the adhesions, anastomotic bursting pres-
sures were measured in-vivo using the setup described
below by two surgeons blind to the groups.
A catheter is inserted through the anus and advanced 2–3
cm proximally so that the tip of the catheter lay at the levelWorld Journal of Emergency Surgery 2006, 1:37 http://www.wjes.org/content/1/1/37
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of the anastomosis. Peritoneal cavity was filled with
saline. Colon was tied with 2/0 silk at 2 cm above and
below the suture line. With both ends tied and a catheter
inside, the segment of the colon was filled with saline
colored with methylene blue at a rate of 4 ml/min using
an infusion pump (Abbott LC 5000 infuser, USA). During
the infusion, pressurs were monitored (Petas KMA 375 S/
N 0013 Turkey) by a pressure transducer (Abbott Single
Transpact, USA). The pressure value was taken while blue
intracolonic flued leaked out to the peritoneal cavity and
recorded as the bursting pressure.
Obtaining the samples
A 2-cm segment of the colon including the anastomosis
was resected, transsected longitudinally and rinsed with
saline to remove intestinal contents. One third of this
sample was fixed in 10% formalin for histopathological
examination. Remaining two-thirds, wrapped in alumi-
num foil, was kept in biochemistry laboratory for tissue
hydroxyproline measuring.
Histopathological examination
Tissue samples obtained from the anastomotic site were
embedded into paraffin blocks following routine histo-
chemical procedures. Four-five micron thick sections were
stained with Hematoxylin-Eosin and examined under
light microscope. Degree of wound healing at the line of
anastomosis was graded on a scale of 1 to 5: Grade I: Fibri-
nopurulent exudate, Grade II: Granulation tissue less than
25%, Grade III: Granulation tissue between 25–75%,
Grade IV: Granulation tissue more than 75% or collagen
fibers less than 25%, Grade V: collagen fibers more than
25%.
Measuring Hydroxyproline level
Two third of 2-cm segment of the colon including the line
of anastomosis was washed with distilled water, dried
with blotter, sectioned into little pieces during tissue
homogenization and kept frozen at -80°C until the day of
the test. Hydroxyproline level was determined by modify-
ing the method described by Woessner [10]. During the
procedure, OH-P standard, chloramin-T, P-dimethyl
amino benzaldehyde, Perchloric acid, Isopropanol, Na
asetat-3 H2O, Na citrate 5,5 H2O, 12 N HCL, 1 mM HCL
chemicals were used. Reagents were added onto the sam-
ple and blank in order, vortexed and incubated in water
bath at 60°C for 25 minutes. Optical density was meas-
ured at 558 nm and the concentration of hydroxyproline
was calculated by comparing it with the blank. Results are
expressed as mg/g dry tissue.
Statistical analyses
Data obtained from the study group were expressed as
mean ± standard deviation. Differences in parameters
among groups were examined using One-way analysis of
variance (ANOVA) and post-hoc analyses with tukey B
and Scheefe tests. Probability (p) value <0.05 was
accepted significant.
Results
No complications including intra-abdominal hemor-
rhage, infection, anastomosis leak, fistula, or abscess were
observed. There were no mortalities during the study.
Intra-abdominal adhesion score of Group 3 was signifi-
cantly lower than remained groups (p < 0.05). Figure 1
reflects these data.
Tissue hydroxyproline levels are presented in Figure 2.
Levels in Group 3 were significantly higher compared to
the Groups 1 and 2 (p < 0.001).
Mean anastomosis bursting pressures were 200 mmHg,
164 mmHg and 240 mmHg in Groups 1, 2 and 3, respec-
tively. Group comparison showed that anastomosis burst-
ing pressure in Group 3 was significantly higher than the
other groups (p < 0.05 between groups 1 and 3; p < 0.001
between groups 2 and 3). Results are presented in Figure
3.
On histopathological examination healing score of the
intestinal tissue was significantly higher in Group 3 than
in Group 2 (p < 0.05). Results are presented in Figure 4.
Discussion
In the present study, we investigated the effects of intra-
peritoneally administrated Bosentan on wound healing
following resection and anastomosis of a segment of
ischemia-induced colon. Bosentan is an endothelin recep-
tor antagonist. When Bosentan administered intraperito-
neally, anastomosis bursting pressure, tissue
hydroxyproline level, and histopathological anastomosis
healing score were higher additionally intra-abdominal
Adhesion grading of the groups * p < 0.05, Group 3 versus  Group 2 Figure 1
Adhesion grading of the groups * p < 0.05, Group 3 versus 
Group 2.World Journal of Emergency Surgery 2006, 1:37 http://www.wjes.org/content/1/1/37
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adhesion scores were also lower. These results suggest that
bosentan increases tissue blood flow by inhibiting the
vasoconstriction effect of endothelins.
Jhonson et al [11] have demonstrated that mesenteric ves-
sels have ET-A and ET-B receptors. Moreover bolus admin-
istration of ET-1, ET-3, proendothelin 1 or proendothelin
3 into the mesenteric circulation resulted in marked
decrease in blood flow. This suggests that mesenteric vas-
cular bed is sensitive to endothelin peptides [12]. It has
been shown in an in-vivo study that Sarafotoxin 6C, an
ET-B receptor agonist, caused dose-dependent, long-term
vasoconstruction in the mesenteric vascular area [13].
Infusion of ET-1 into the superior mesenteric artery
increases mucosal permeability, causes accumulation of
polimorphonuclear cell (PMN) and mucosal dysfunction
[14]. ET-1 is known to play an important role of in the
pathogenesis of gastrointestinal mucosal damage whereas
there is little information on the effects of ET-3 on the
alterations on intestinal inflammatory responce. Small
intestines are the major source of ET-3 production [15].
ET-3 decreases superior mesenteric artery (SMA) blood
flow significantly and plays important roles in intestinal
mucosal dysfunction and tissue PMN infiltration [16]. In
the present study tissue endothelin levels were not assayed
but in experimental strangulated small bowel obstruc-
tions, the release and concentration of ET-1 has been
shown to increased in the venous blood of strangulated
intestinal loop. In the same study Endothelin-1 has been
shown to increase tissue vascular resistance in the intesti-
nal mucosa of the strangulated specimen significantly fol-
lowing its induction in strangulated obstruction. It has
been shown that animals that received Bosentan treat-
ment had significantly lower mucosal vascular resistance
compared to untreated animals [6].
Bosentan is a non-peptide receptor antagonist of both ET-
A and ET-B receptors. Bosentan can be administered orally
or parenterally. Its half life is 5.4 hours. In this study
Bosentan was administered intraperitoneally. We con-
cluded that Bosentan was not effected only locally. Bosen-
tan is used in the treatment of pulmonary hypertension.
There are ongoing research on the effects of Bosentan in
heart failure, hypertension, subarachnoidal hemorrhage,
acute and chronic renal failure, migraine, and coronary
artery disease [17]. To the best of our knowledge there are
no studies on the effects of Bosentan on wound healing.
Wound healing in the gastrointestinal system involves
related processes such as hemostasis and inflammation,
proliferation-fibroplasia and maturation and remodeling.
Delay or problem in any of these stages results with a
delay in healing [18]. There are numerous local and sys-
temic factors that affect anastomotic healing. The most
important local factor is the perfusion and oxygenation of
the site of anastomosis. To achieve safe anastomosis,
intestinal blood flow should exceed 30% [19-21]. Becapl-
ermin, a platelet derived growth factor has been used
locally on normal and ischemic colon anastomosis and
Healing score of the intestinal tissue * p < 0.05, Group 2 ver- sus Group 3 Figure 4
Healing score of the intestinal tissue * p < 0.05, Group 2 ver-
sus Group 3.
Tissue hydroxyproline levels in groups (mg/g dry tissue) Figure 2
Tissue hydroxyproline levels in groups (mg/g dry tissue). *** 
p < 0.001, Group 3 versus Group 1 and group 2.
Bursting pressures in groups(mmHg) * p < 0.05, Group 1  versus Group 3 Figure 3
Bursting pressures in groups(mmHg) * p < 0.05, Group 1 
versus Group 3. *** p < 0.001 Group 2 versus Group 3.Publish with BioMed Central    and   every 
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eliminated the unfavorable effects of ischemia on the
colon anastomosis [22]. We believe that Bosentan
decreased the adverse effects of ischemia on the mucosa
and submucosa during the initial stage of wound healing,
thus positively contributed to wound healing parameters.
Adhesions are encountered after many intra-abdominal
surgical procedures. Tissue ischemia is believed to be the
most important etiological factor in the adhesion forma-
tion because vascular bridges are formed between the
ischemic and adjacent healthy organs [7]. The fact that
adhesion scores in Bosentan-administered group was
lower than the other groups led us to believe that this was
due to increase of blood flow on splanchnic area.
As a result, Bosentan decreased the adhesion formation
and increased anastomotic healing following resection
and anastomosis for strangulated colonic obstruction. We
believe the findings of this study should be warrented by
large numbered experimental and prospective clinical
studies.
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